Literature DB >> 25512464

Long-term active surveillance for prostate cancer: answers and questions.

Matthew R Cooperberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25512464     DOI： 10.1200/JCO.2014.59.2329

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.

Authors:  Boris Gershman; Paul Maroni; Jon C Tilburt; Robert J Volk; Badrinath Konety; Charles L Bennett; Alexander Kutikov; Marc C Smaldone; Victor Chen; Simon P Kim
Journal:  World J Urol       Date:  2019-01-22       Impact factor: 4.226

Review 2.  Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.

Authors:  Andrzej M Bugaj
Journal:  World J Methodol       Date:  2016-03-26

3.  Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management.

Authors:  Scott P Kelly; Stephen K Van Den Eeden; Richard M Hoffman; David S Aaronson; Tania Lobo; George Luta; Amethyst D Leimpter; Jun Shan; Arnold L Potosky; Kathryn L Taylor
Journal:  J Urol       Date:  2016-04-14       Impact factor: 7.450

4.  Applying precision medicine to the active surveillance of prostate cancer.

Authors:  Chad A Reichard; Andrew J Stephenson; Eric A Klein
Journal:  Cancer       Date:  2015-07-06       Impact factor: 6.860

5.  The Quantitative Criteria Based on the Fractal Dimensions, Entropy, and Lacunarity for the Spatial Distribution of Cancer Cell Nuclei Enable Identification of Low or High Aggressive Prostate Carcinomas.

Authors:  Przemyslaw Waliszewski
Journal:  Front Physiol       Date:  2016-02-11       Impact factor: 4.566

6.  The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized 13C MRSI.

Authors:  Robert Bok; Jessie Lee; Renuka Sriram; Kayvan Keshari; Subramaniam Sukumar; Saeed Daneshmandi; David E Korenchan; Robert R Flavell; Daniel B Vigneron; John Kurhanewicz; Pankaj Seth
Journal:  Cancers (Basel)       Date:  2019-02-22       Impact factor: 6.639

7.  Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.

Authors:  Shellie D Ellis; Soohyun Hwang; Emily Morrow; Kim S Kimminau; Kelly Goonan; Laurie Petty; Edward Ellerbeck; J Brantley Thrasher
Journal:  BMC Cancer       Date:  2021-05-31       Impact factor: 4.430

8.  Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: No.

Authors:  Nishanth Krishnananthan; Nathan Lawrentschuk
Journal:  Int Braz J Urol       Date:  2016 May-Jun       Impact factor: 1.541

9.  Elevated Tumor Lactate and Efflux in High-grade Prostate Cancer demonstrated by Hyperpolarized 13C Magnetic Resonance Spectroscopy of Prostate Tissue Slice Cultures.

Authors:  Renuka Sriram; Mark Van Criekinge; Justin DeLos Santos; Fayyaz Ahamed; Hecong Qin; Rosalie Nolley; Romelyn DeLos Santos; Z Laura Tabatabai; Robert A Bok; Kayvan R Keshari; Daniel B Vigneron; Donna M Peehl; John Kurhanewicz
Journal:  Cancers (Basel)       Date:  2020-02-26       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.